<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Craniosynostosis syndromes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Craniosynostosis syndromes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Craniosynostosis syndromes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Helen V Firth, DM, FRCP, FMedSci</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Craniosynostosis, defined as premature fusion or growth arrest at one or more of the cranial sutures, most commonly occurs sporadically as an isolated defect. In contrast, syndromic craniosynostosis typically involves multiple sutures as part of a larger constellation of associated anomalies.</p><p>Syndromes most frequently associated with craniosynostosis include Apert, Crouzon, Pfeiffer, Carpenter, and Saethre-Chotzen [<a href="#rid1">1</a>]. Syndromic craniosynostoses are often sporadic and are the result of de novo autosomal dominant mutations involving fibroblast growth factor receptors (FGFRs) and TWIST genes. Common features of these conditions are skull-base abnormalities, midface hypoplasia, and limb anomalies. The etiology and clinical features of these disorders are reviewed here. The diagnosis and surgical management of nonsyndromic craniosynostosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">APERT SYNDROME</span><span class="headingEndMark"> — </span>Apert syndrome (acrocephalosyndactyly type I, MIM #101200) is an autosomal dominant disorder that occurs in 6 to 15.5 out of 1 million livebirths [<a href="#rid2">2-6</a>]. Most cases are sporadic. Mutations in the gene encoding fibroblast growth factor receptor 2 (<em>FGFR2</em>), located on chromosome 10, account for almost all known cases [<a href="#rid7">7,8</a>].</p><p>The fibroblast growth factor (FGF) family, which consists of 18 structurally related proteins, plays a central role in the growth and differentiation of mesenchymal and neuroectodermal cells. FGFRs consist of four tyrosine kinases that bind FGF and play a substantial role in signal transduction. FGFRs regulate cranial suture fusion on a macroscopic level. Animal studies suggest that defective FGF signal transduction due to receptor malfunction leads to growth arrest of the cranium as well as the midface [<a href="#rid9">9</a>].</p><p>Two common mutations in the exon IIIa of <em>FGFR2</em> are associated with Apert syndrome [<a href="#rid10">10</a>]. In a mouse model, small hairpin RNA was used to suppress transcription of the mutant <em>FGFR2</em> allele. This prevented the development of Apert-like syndrome in the treated mice [<a href="#rid11">11</a>]. Mutations in the FGFR also have been linked to Crouzon [<a href="#rid12">12,13</a>], Pfeiffer, Muenke [<a href="#rid14">14</a>], Jackson-Weiss [<a href="#rid15">15</a>], and Saethre-Chotzen [<a href="#rid16">16</a>] syndromes.</p><p class="headingAnchor" id="H3"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Apert syndrome manifests clinically as two noticeable craniofacial defects, bicoronal synostosis and maxillary hypoplasia, that cause a flat, recessed forehead and flat midface. In addition, affected patients typically present with protruding eyes (exorbitism), widely separated orbits (hypertelorism), and a laterally down-sloping slant [<a href="#rid17">17</a>]. Low-set ears are often accompanied by an abnormally small, flat nasal structure with a bulbous tip.</p><p>The palate is often highly arched and may be associated with clefting in up to one-third of patients. The maxillary dental arch is frequently V shaped. A class 3 malocclusion (underbite) is considered a nearly universal finding (<a class="graphic graphic_picture graphicRef77494" href="/d/graphic/77494.html" rel="external">picture 1</a>).</p><p>Strabismus is a frequent finding in Apert syndrome, as is hearing loss resulting from persistent middle-ear effusion [<a href="#rid18">18,19</a>]. The small, malformed pharynx and hypoplastic midface may result in airway compromise. Severe acne vulgaris develops in 70 percent of patients with Apert syndrome and frequently involves the extremities.</p><p>Syndactyly is a characteristic feature of Apert syndrome that permits distinction from other similar syndromes (<a class="graphic graphic_picture graphicRef57946" href="/d/graphic/57946.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef69731" href="/d/graphic/69731.html" rel="external">picture 3</a>). Patients with Apert syndrome typically have a complex syndactyly known as mitten hand, in which the index, middle, ring, and fifth fingers share fused bone and soft tissue components with a common nail bed. The thumb is often relatively well formed and mobile. A similar syndactyly is frequently demonstrated in the feet [<a href="#rid20">20</a>].</p><p>Other features of Apert syndrome were described in a review of 136 cases [<a href="#rid21">21</a>]. The characteristic megalencephaly resulted in a mean birth weight and length &gt;50<sup>th</sup> percentile. Linear growth slowed during childhood, typically resulting in values between the 5<sup>th</sup> and 50<sup>th</sup> percentiles. This slowing became more pronounced from adolescence to adulthood. Some affected patients had associated central nervous system (CNS) abnormalities, including malformations of the corpus callosum and limbic structures, gyral abnormalities, hypoplastic white matter, and heterotopic gray matter. Most patients had ventriculomegaly, resulting from distortion imposed upon a large brain within a misshapen skull; however, progressive hydrocephalus occurred in only 10 percent of cases. Cardiovascular (atrial septal defect, ventricular septal defect, patent foramen ovale, overriding aorta) and genitourinary (hydronephrosis, cryptorchidism) anomalies occurred in 10 and 9.6 percent of cases, respectively. Intelligence varied from normal to mental deficiency. In another case series, intelligence quotient (IQ) was &lt;70 in 67 percent of patients [<a href="#rid22">22</a>]. Three of nine patients (average age 30 years, range 22 to 41 years) followed long term in another series received college degrees, and two graduated from high school [<a href="#rid23">23</a>]. All reported good integration into society with normal social lives.</p><p class="headingAnchor" id="H4"><span class="h2">Surgery</span><span class="headingEndMark"> — </span>Surgical correction is a three-staged process that parallels facial growth and psychosocial development [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Craniosynostosis release</strong> – Classically, craniosynostosis release with fronto-orbital advancement is completed at 6 to 12 months of age if intracranial pressure (ICP) is normal [<a href="#rid24">24-26</a>]. However, elevated ICP may occur in up to 43 percent of cases. In this event, prompt surgical advancement and potentially ventriculoperitoneal shunt placement is required [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">Increasingly, surgeons are performing an initial procedure to distract the posterior skull in the first year of life. In addition to increasing intracranial volume, this reduces the appearance of a towering skull. The fronto-orbital advancement in these cases is deferred to a later date [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Midface advancement</strong> – Despite early release of craniosynostosis, patients may require additional correction of cranial dysmorphism, such as brachycephaly, orbital dystopia, or midface hypoplasia, before entering school.</p><p></p><p class="bulletIndent1">The timing of this corrective procedure, known as midface advancement, is controversial. Surgical correction at four to eight years of age provides the child with improved appearance during this psychologically formative period. However, the advanced midface has limited anteroposterior growth potential, and, therefore, relapse occurs in most cases as the mandible continues to develop normally. Most patients need readvancement in late adolescence [<a href="#rid29">29,30</a>]. An alternate approach is to perform midface advancement at 9 to 12 years of age, when growth is nearing completion and the rate of relapse is decreased. Although early coronal release and frontal advancement with reshaping reduces further dysmorphic changes, it is thought that such correction has little effect on mentation.</p><p></p><p class="bulletIndent1">The two procedural options are the Le Fort III osteotomy or monobloc advancement by distraction osteogenesis [<a href="#rid23">23,25,26</a>]. Le Fort II is typically used if forehead retrusion is not present. Distraction osteogenesis involves methodical lengthening of bone by gradual mechanical displacement of a surgically created fracture. Application of this technique in the correction of midfacial structure deformity may produce a more durable result in the pediatric population and appears to improve the outcome of midface advancement compared with traditional techniques.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Correction of hypertelorism</strong> – Hypertelorism may be corrected via resection of a wedge of interorbital bone. Upon removal of the interorbital bone, the orbits may be repositioned in a more medial location for improved cosmesis. If required, mandible surgery with maxillary advancement and orthodontics following maturation may enhance long-term cosmetic outcome.</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CROUZON SYNDROME</span><span class="headingEndMark"> — </span>Crouzon syndrome (craniofacial dysostosis type I, MIM #123500) is autosomal dominant and occurs at a frequency of 16 in 1 million livebirths [<a href="#rid13">13,31,32</a>]. Crouzon syndrome is predominantly caused by mutations in fibroblast growth factor receptor 2 (<em>FGFR2)</em> [<a href="#rid12">12,13</a>], although fibroblast growth factor receptor 3 <em>(FGFR3)</em> mutations have been identified in individuals with Crouzon syndrome and acanthosis nigricans [<a href="#rid33">33</a>]. A link between advanced paternal age and sporadic cases of Crouzon syndrome has also been demonstrated, as is often seen in autosomal dominant disorders caused by new mutations [<a href="#rid34">34</a>].</p><p>Crouzon syndrome is characterized by a tall, flattened forehead (secondary to bicoronal synostosis), proptosis, a beaked nose, and midface hypoplasia. The degree of facial deformity is milder than that of Apert syndrome [<a href="#rid35">35</a>], and cleft palate is rare. Also in contrast to Apert syndrome, patients with Crouzon syndrome typically have structurally normal hands and feet, as well as normal intelligence.</p><p>Cervical spine abnormalities occur in up to one-third of patients and must be thoroughly evaluated before surgical correction of craniosynostosis. The surgical treatment is similar in timing and technique to that used in Apert syndrome [<a href="#rid36">36,37</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PFEIFFER SYNDROME</span><span class="headingEndMark"> — </span>Pfeiffer syndrome (Pfeiffer-type acrocephalosyndactyly type V, MIM #101600) is the result of an autosomal dominant genetic defect. The majority of cases occur sporadically, although pedigrees are reported [<a href="#rid38">38</a>]. Pfeiffer syndrome is most commonly associated with mutations in fibroblast growth factor receptor 1 <em>(FGFR1)</em> and fibroblast growth factor receptor 2 <em>(FGFR2)</em> [<a href="#rid34">34,39,40</a>]. Several patients have demonstrated a point mutation at the Ser351Cys locus (serine changed to cysteine at amino acid codon 351) of <em>FGFR2</em>, which appears to result in a more severe phenotype with decreased prognosis for survival [<a href="#rid41">41,42</a>].</p><p>The clinical features of Pfeiffer syndrome include variable degrees of craniosynostosis and midface hypoplasia. Broad thumbs and abnormally wide great toes are often paired with partial syndactyly of the second and third fingers, as well as second, third, and fourth toes [<a href="#rid43">43,44</a>]. The presence and extent of syndactyly are variable. Skeletal (eg, radiohumeral synostosis of the elbow), central nervous system (CNS; eg, hydrocephalus), and gastrointestinal abnormalities (eg, imperforate anus) also frequently occur [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H1696523"><span class="h2">Clinical subtypes</span><span class="headingEndMark"> — </span>Pfeiffer syndrome is classified into three subtypes. The classification is helpful in predicting prognosis for mental impairment and survival.</p><p>Patients with type 1 Pfeiffer syndrome have the classic phenotype with symmetric bicoronal craniosynostosis, variable syndactyly, broad thumbs, and widened great toes. Intelligence is normal or near normal, and most patients survive to adulthood, although little follow-up data are available given the rarity of this syndrome [<a href="#rid44">44</a>]. Autosomal dominant inheritance is the rule, although sporadic cases occur.</p><p>Types 2 and 3 have a more severe phenotypic expression. In addition to the usual bicoronal craniosynostosis, multiple other sutures are frequently involved. Types 2 and 3 are similar in clinical features and outcome; however, they may be differentiated by the cloverleaf skull anomaly [<a href="#rid45">45</a>], which is only present in type 2.</p><p>Type 2 Pfeiffer syndrome is also characterized by severe ocular proptosis, ankylosis of the elbows, broad thumbs and great toes, as well as visceral anomalies [<a href="#rid44">44</a>]. There is severe CNS involvement, most often manifest as hydrocephalus, with poor prognosis and frequent early death [<a href="#rid46">46</a>]. To date, all documented cases of type 2 have been sporadic.</p><p>Type 3 Pfeiffer syndrome is similar to type 2; however, the cloverleaf skull deformity is absent. Severe ocular proptosis is present, and patients often have a markedly shorter anterior cranial base. Severe neurologic defects are common, and patients typically die early [<a href="#rid46">46</a>]. As with type 2 Pfeiffer syndrome, all documented cases have occurred sporadically.</p><p class="headingAnchor" id="H9"><span class="h2">Surgical management</span><span class="headingEndMark"> — </span>Mild forms of Pfeiffer syndrome can be effectively managed via fronto-orbital and Le Fort III advancement. Severe cases often require extensive surgical release and ventriculoperitoneal shunting for hydrocephalus management.</p><p class="headingAnchor" id="H10"><span class="h1">CARPENTER SYNDROME</span><span class="headingEndMark"> — </span>Carpenter syndrome, also known as acrocephalopolysyndactyly type II (MIM #201000), is a rare autosomal recessive disorder [<a href="#rid47">47</a>]. It is associated with mutations in <em>RAB23</em> (RAS-associated protein), a guanosine triphosphate hydrolase (GTPase) involved in intracellular membrane trafficking regulation [<a href="#rid48">48,49</a>].</p><p>Patients affected by Carpenter syndrome have brachycephaly with concurrent coronal, sagittal, and lambdoid craniosynostosis [<a href="#rid50">50</a>]. The supraorbital ridges are shallow, the nasal bridge is flat, and the lateral canthi are displaced laterally with or without inner canthal folds. Other craniofacial features include a hypoplastic mandible and/or maxilla, low-set and malformed ears, and a narrow, high-arched palate.</p><p>Patients with Carpenter syndrome also are frequently affected by preaxial polydactyly (supernumerary digits of the medial ray). Common findings include brachydactyly (short digits) of the hands with clinodactyly (curved fingers), partial syndactyly, and camptodactyly (permanent flexion of the digit).</p><p>Cardiovascular anomalies are common in patients with Carpenter syndrome. Up to 50 percent demonstrate ventricular or atrial septal defect, patent ductus arteriosus, pulmonic stenosis, tetralogy of Fallot, or transposition of the great arteries [<a href="#rid50">50</a>]. Hypogonadism and omphalocele also have been linked to Carpenter syndrome. In addition, patients tend to be obese and moderately mentally impaired.</p><p>Surgical standard of care consists of early release of craniosynostoses with fronto-orbital advancement [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H12"><span class="h1">SAETHRE-CHOTZEN SYNDROME</span><span class="headingEndMark"> — </span>Saethre-Chotzen syndrome, also known as acrocephalosyndactyly type III (MIM #101400), is an autosomal dominant disorder [<a href="#rid52">52</a>]. Mutations in the <em>TWIST</em> gene, which is located on chromosome 7p21.1 and encodes a basic helix-loop-helix transcriptional regulator, have been identified in many patients [<a href="#rid53">53,54</a>]. Mutations in fibroblast growth factor receptor 2 <em>(FGFR2)</em> also have been reported [<a href="#rid16">16</a>]. <em>TWIST</em> encodes for a basic transcription factor that is responsible for mesenchymal cell development during cranial neuralization [<a href="#rid55">55,56</a>]. In a study of calvaria osteoblastic cells with the <em>TWIST</em> mutation, osteocalcin gene expression was decreased and bone formation increased compared with controls [<a href="#rid57">57</a>].</p><p>Defects in the <em>TWIST</em> gene also have been linked to mutations in <em>FGFR2</em>, providing supportive evidence for an interaction between <em>TWIST</em> and FGFR genes during development. On a macroscopic level, these cellular alterations may contribute to premature cranial ossification.</p><p>Patients affected by Saethre-Chotzen syndrome typically have craniosynostosis of coronal, lambdoid, and/or metopic sutures (<a class="graphic graphic_figure graphicRef69620" href="/d/graphic/69620.html" rel="external">figure 1</a>). The characteristic facial appearance includes a towering (turricephalic) forehead, low-set hairline, facial asymmetry with septal deviation, and ptosis of the upper eyelids [<a href="#rid58">58,59</a>]. Cutaneous syndactyly, usually partial, frequently occurs and involves the second and third fingers and/or the third and fourth toes [<a href="#rid44">44</a>]. Most patients have normal intelligence.</p><p>The underlying craniosynostosis frequently is mild and requires only a simple operative release. However, more severely affected patients may require cranial remodeling.</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Craniosynostosis, defined as premature fusion or growth arrest at one or more of the cranial sutures, most commonly occurs sporadically as an isolated defect. In contrast, syndromic craniosynostosis typically involves multiple sutures as part of a larger constellation of associated anomalies. (See  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis"</a> and  <a class="medical medical_review" href="/d/html/2910.html" rel="external">"Overview of craniosynostosis", section on 'Introduction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Apert syndrome</strong> – Craniofacial features of Apert syndrome (acrocephalosyndactyly type I) include bicoronal synostosis, maxillary hypoplasia, protruding eyes with a laterally down-sloping slant, hypertelorism, low-set ears, and high-arched palate. Additional features may include intellectual disability, strabismus, hearing loss, severe acne, and syndactyly of the hands and feet. (See <a class="local">'Apert syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Crouzon syndrome</strong> – Craniofacial features of Crouzon syndrome (craniofacial dysostosis type I) include bicoronal synostosis, proptosis, and midface hypoplasia. The hands are typically normal, as is intelligence. (See <a class="local">'Crouzon syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pfeiffer syndrome</strong> – Craniofacial features of Pfeiffer syndrome (acrocephalosyndactyly type V) include variable degrees of craniosynostosis, midface hypoplasia, and proptosis. The presence and extent of syndactyly is variable. Additional manifestations may include broad thumbs and great toes, radiohumeral synostosis, hydrocephalus, and imperforate anus. Type 1 is mild. Types 2 and 3 are associated with severe neurologic defects that lead to early death. (See <a class="local">'Pfeiffer syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Carpenter syndrome</strong> – Craniofacial features of Carpenter syndrome (acrocephalopolysyndactyly type II) include coronal, sagittal, and lambdoid craniosynostosis; shallow supraorbital ridges; flat nasal bridge; laterally displaced lateral canthi; hypoplastic mandible and/or maxilla; low-set and malformed ears; and narrow, high-arched palate. Additional features may include abnormalities of the digits (supernumerary, short, curved, permanent flexion), cardiovascular anomalies, hypogonadism, omphalocele, and obesity. (See <a class="local">'Carpenter syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Saethre-Chotzen syndrome</strong> – Craniofacial features of Saethre-Chotzen syndrome (acrocephalosyndactyly type III) include craniosynostosis of coronal, lambdoid, and/or metopic sutures (<a class="graphic graphic_figure graphicRef69620" href="/d/graphic/69620.html" rel="external">figure 1</a>), towering (turricephalic) forehead, low-set hairline, facial asymmetry with septal deviation, and ptosis. Many patients often have partial syndactyly. (See <a class="local">'Saethre-Chotzen syndrome'</a> above.)</p><p></p><p class="headingAnchor" id="H736187156"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Patrick Cole, MD and Larry H Hollier, Jr, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">GeneReviews: FGFR-Related Craniosynostosis Syndromes http://www.ncbi.nlm.nih.gov/books/NBK1455/ (Accessed on July 15, 2011).</li><li><a class="nounderline abstract_t">Apert E. De l'acrocephalosyndactylie. Bull Soc Med Paris 1906; 23:1310.</a></li><li><a class="nounderline abstract_t">Tolarova MM, Harris JA, Ordway DE, Vargervik K. Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome. Am J Med Genet 1997; 72:394.</a></li><li><a class="nounderline abstract_t">BLANK CE. Apert's syndrome (a type of acrocephalosyndactyly)-observations on a British series of thirty-nine cases. Ann Hum Genet 1960; 24:151.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr, Kreiborg S, Lammer EJ, et al. Birth prevalence study of the Apert syndrome. Am J Med Genet 1992; 42:655.</a></li><li><a class="nounderline abstract_t">Czeizel AE, Elek C, Susánszky E. Birth prevalence study of the Apert syndrome. Am J Med Genet 1993; 45:392.</a></li><li><a class="nounderline abstract_t">Wilkie AO, Slaney SF, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995; 9:165.</a></li><li><a class="nounderline abstract_t">Ibrahimi OA, Eliseenkova AV, Plotnikov AN, et al. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A 2001; 98:7182.</a></li><li><a class="nounderline abstract_t">Purushothaman R, Cox TC, Maga AM, Cunningham ML. Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes. Birth Defects Res A Clin Mol Teratol 2011; 91:603.</a></li><li><a class="nounderline abstract_t">Girisha KM, Phadke SR, Khan F, Agrawal S. S252W mutation in Indian patients of Apert syndrome. Indian Pediatr 2006; 43:733.</a></li><li><a class="nounderline abstract_t">Shukla V, Coumoul X, Wang RH, et al. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 2007; 39:1145.</a></li><li><a class="nounderline abstract_t">Rutland P, Pulleyn LJ, Reardon W, et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 1995; 9:173.</a></li><li><a class="nounderline abstract_t">Reardon W, Winter RM, Rutland P, et al. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994; 8:98.</a></li><li><a class="nounderline abstract_t">Muenke M, Gripp KW, McDonald-McGinn DM, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997; 60:555.</a></li><li><a class="nounderline abstract_t">Park WJ, Meyers GA, Li X, et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 1995; 4:1229.</a></li><li><a class="nounderline abstract_t">Freitas EC, Nascimento SR, de Mello MP, Gil-da-Silva-Lopes VL. Q289P mutation in FGFR2 gene causes Saethre-Chotzen syndrome: some considerations about familial heterogeneity. Cleft Palate Craniofac J 2006; 43:142.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr, Kreiborg S. A clinical study of the craniofacial features in Apert syndrome. Int J Oral Maxillofac Surg 1996; 25:45.</a></li><li><a class="nounderline abstract_t">Rajenderkumar D, Bamiou DE, Sirimanna T. Audiological profile in Apert syndrome. Arch Dis Child 2005; 90:592.</a></li><li><a class="nounderline abstract_t">de Jong T, Toll MS, de Gier HH, Mathijssen IM. Audiological profile of children and young adults with syndromic and complex craniosynostosis. Arch Otolaryngol Head Neck Surg 2011; 137:775.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr, Kreiborg S. Hands and feet in the Apert syndrome. Am J Med Genet 1995; 57:82.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr, Kreiborg S. An updated pediatric perspective on the Apert syndrome. Am J Dis Child 1993; 147:989.</a></li><li><a class="nounderline abstract_t">Renier D, Arnaud E, Cinalli G, et al. Prognosis for mental function in Apert's syndrome. J Neurosurg 1996; 85:66.</a></li><li><a class="nounderline abstract_t">Allam KA, Wan DC, Khwanngern K, et al. Treatment of apert syndrome: a long-term follow-up study. Plast Reconstr Surg 2011; 127:1601.</a></li><li><a class="nounderline abstract_t">Tessier P. The definitive plastic surgical treatment of the severe facial deformities of craniofacial dysostosis. Crouzon's and Apert's diseases. Plast Reconstr Surg 1971; 48:419.</a></li><li><a class="nounderline abstract_t">Cedars MG, Linck DL 2nd, Chin M, Toth BA. Advancement of the midface using distraction techniques. Plast Reconstr Surg 1999; 103:429.</a></li><li><a class="nounderline abstract_t">Wong GB, Kakulis EG, Mulliken JB. Analysis of fronto-orbital advancement for Apert, Crouzon, Pfeiffer, and Saethre-Chotzen syndromes. Plast Reconstr Surg 2000; 105:2314.</a></li><li><a class="nounderline abstract_t">Mouradian WE. Controversies in the diagnosis and management of craniosynostosis: a panel discussion. Cleft Palate Craniofac J 1998; 35:190.</a></li><li><a class="nounderline abstract_t">Hopper RA. New trends in cranio-orbital and midface distraction for craniofacial dysostosis. Curr Opin Otolaryngol Head Neck Surg 2012; 20:298.</a></li><li><a class="nounderline abstract_t">McCarthy JG, Grayson B, Bookstein F, et al. Le Fort III advancement osteotomy in the growing child. Plast Reconstr Surg 1984; 74:343.</a></li><li><a class="nounderline abstract_t">Shetye PR, Kapadia H, Grayson BH, McCarthy JG. A 10-year study of skeletal stability and growth of the midface following Le Fort III advancement in syndromic craniosynostosis. Plast Reconstr Surg 2010; 126:973.</a></li><li><a class="nounderline abstract_t">Mulliken JB, Steinberger D, Kunze S, Müller U. Molecular diagnosis of bilateral coronal synostosis. Plast Reconstr Surg 1999; 104:1603.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr, Kreiborg S. Birth prevalence studies of the Crouzon syndrome: comparison of direct and indirect methods. Clin Genet 1992; 41:12.</a></li><li><a class="nounderline abstract_t">Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995; 11:462.</a></li><li><a class="nounderline abstract_t">Glaser RL, Jiang W, Boyadjiev SA, et al. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 2000; 66:768.</a></li><li><a class="nounderline abstract_t">Kreiborg S, Cohen MM Jr. Is craniofacial morphology in Apert and Crouzon syndromes the same? Acta Odontol Scand 1998; 56:339.</a></li><li><a class="nounderline abstract_t">Tulasne JF, Tessier PL. Long-term results of Le Fort III advancement in Crouzon's syndrome. Cleft Palate J 1986; 23 Suppl 1:102.</a></li><li><a class="nounderline abstract_t">Meling TR, Høgevold HE, Due-Tønnessen BJ, Skjelbred P. Comparison of perioperative morbidity after LeFort III and monobloc distraction osteogenesis. Br J Oral Maxillofac Surg 2011; 49:131.</a></li><li><a class="nounderline abstract_t">Cohen MM Jr. Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis. Am J Med Genet 1993; 45:300.</a></li><li><a class="nounderline abstract_t">Cornejo-Roldan LR, Roessler E, Muenke M. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome. Hum Genet 1999; 104:425.</a></li><li><a class="nounderline abstract_t">Muenke M, Schell U, Hehr A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994; 8:269.</a></li><li><a class="nounderline abstract_t">Stevens CA, Roeder ER. Ser351Cys mutation in the fibroblast growth factor receptor 2 gene results in severe Pfeiffer syndrome. Clin Dysmorphol 2006; 15:187.</a></li><li><a class="nounderline abstract_t">Oliveira NA, Alonso LG, Fanganiello RD, Passos-Bueno MR. Further evidence of association between mutations in FGFR2 and syndromic craniosynostosis with sacrococcygeal eversion. Birth Defects Res A Clin Mol Teratol 2006; 76:629.</a></li><li><a class="nounderline abstract_t">PFEIFFER RA. [DOMINANT HEREDITARY ACROCEPHALOSYNDACTYLIA]. Z Kinderheilkd 1964; 90:301.</a></li><li class="breakAll">Jones KL. Pfeiffer syndrome (Pfeiffer-type acrocephalosyndactyly). In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.472.</li><li><a class="nounderline abstract_t">Cohen MM Jr. Cloverleaf skulls: etiologic heterogeneity and pathogenetic variability. J Craniofac Surg 2009; 20 Suppl 1:652.</a></li><li><a class="nounderline abstract_t">Robin NH, Scott JA, Arnold JE, et al. Favorable prognosis for children with Pfeiffer syndrome types 2 and 3: implications for classification. Am J Med Genet 1998; 75:240.</a></li><li><a class="nounderline abstract_t">Hidestrand P, Vasconez H, Cottrill C. Carpenter syndrome. J Craniofac Surg 2009; 20:254.</a></li><li><a class="nounderline abstract_t">Jenkins D, Seelow D, Jehee FS, et al. RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 2007; 80:1162.</a></li><li><a class="nounderline abstract_t">Alessandri JL, Dagoneau N, Laville JM, et al. RAB23 mutation in a large family from Comoros Islands with Carpenter syndrome. Am J Med Genet A 2010; 152A:982.</a></li><li class="breakAll">Jones KL. Carpenter syndrome. In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.484.</li><li><a class="nounderline abstract_t">Kadakia S, Helman SN, Healy NJ, et al. Carpenter syndrome: a review for the craniofacial surgeon. J Craniofac Surg 2014; 25:1653.</a></li><li class="breakAll">GeneReviews: Saethre-Chotzen Syndrome. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK1189/ (Accessed on July 15, 2011).</li><li><a class="nounderline abstract_t">el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 1997; 15:42.</a></li><li><a class="nounderline abstract_t">Johnson D, Horsley SW, Moloney DM, et al. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet 1998; 63:1282.</a></li><li><a class="nounderline abstract_t">El Ghouzzi V, Lajeunie E, Le Merrer M, et al. Mutations within or upstream of the basic helix-loop-helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome. Eur J Hum Genet 1999; 7:27.</a></li><li><a class="nounderline abstract_t">El Ghouzzi V, Legeai-Mallet L, Aresta S, et al. Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet 2000; 9:813.</a></li><li><a class="nounderline abstract_t">Yousfi M, Lasmoles F, Lomri A, et al. Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest 2001; 107:1153.</a></li><li><a class="nounderline abstract_t">Saethre H. Oxycephaly (turmschadel), its neuro-psychiatric symptoms, pathogenesis, and heredity. Norsk Mag Laegevidensk 1931; 92:392.</a></li><li><a class="nounderline abstract_t">Chotzen F. Unusual familial developmental disturbance of face (acrocephalosyndactylia, craniofacial dysostosis and hypertelorism). Monatschr Kinderh 1932; 55:97.</a></li></ol></div><div id="topicVersionRevision">Topic 2942 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.ncbi.nlm.nih.gov/books/NBK1455/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : GeneReviews: FGFR-Related Craniosynostosis Syndromes http://www.ncbi.nlm.nih.gov/books/NBK1455/ (Accessed on July 15, 2011).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : De l'acrocephalosyndactylie</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9375719" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13801313" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Apert's syndrome (a type of acrocephalosyndactyly)-observations on a British series of thirty-nine cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1303629" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Birth prevalence study of the Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8434630" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Birth prevalence study of the Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7719344" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11390973" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21538817" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16951439" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : S252W mutation in Indian patients of Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694057" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7719345" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7987400" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9042914" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8528214" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16526917" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Q289P mutation in FGFR2 gene causes Saethre-Chotzen syndrome: some considerations about familial heterogeneity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833300" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A clinical study of the craniofacial features in Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15908623" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Audiological profile in Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21844411" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Audiological profile of children and young adults with syndromic and complex craniosynostosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7645606" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Hands and feet in the Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8362820" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An updated pediatric perspective on the Apert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8683284" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prognosis for mental function in Apert's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21187805" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Treatment of apert syndrome: a long-term follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4942075" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The definitive plastic surgical treatment of the severe facial deformities of craniofacial dysostosis. Crouzon's and Apert's diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9950528" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Advancement of the midface using distraction techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10845283" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Analysis of fronto-orbital advancement for Apert, Crouzon, Pfeiffer, and Saethre-Chotzen syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9603550" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Controversies in the diagnosis and management of craniosynostosis: a panel discussion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22894998" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : New trends in cranio-orbital and midface distraction for craniofacial dysostosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6473555" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Le Fort III advancement osteotomy in the growing child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20463620" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A 10-year study of skeletal stability and growth of the midface following Le Fort III advancement in syndromic craniosynostosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10541159" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Molecular diagnosis of bilateral coronal synostosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1633640" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Birth prevalence studies of the Crouzon syndrome: comparison of direct and indirect methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7493034" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10712195" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10066112" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Is craniofacial morphology in Apert and Crouzon syndromes the same?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3469041" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Long-term results of Le Fort III advancement in Crouzon's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20226576" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Comparison of perioperative morbidity after LeFort III and monobloc distraction osteogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8434615" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10394936" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7874169" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16760743" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Ser351Cys mutation in the fibroblast growth factor receptor 2 gene results in severe Pfeiffer syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16955501" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Further evidence of association between mutations in FGFR2 and syndromic craniosynostosis with sacrococcygeal eversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14316612" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : [DOMINANT HEREDITARY ACROCEPHALOSYNDACTYLIA].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14316612" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : [DOMINANT HEREDITARY ACROCEPHALOSYNDACTYLIA].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19293681" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cloverleaf skulls: etiologic heterogeneity and pathogenetic variability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9475589" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Favorable prognosis for children with Pfeiffer syndrome types 2 and 3: implications for classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19165041" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Carpenter syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17503333" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20358613" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : RAB23 mutation in a large family from Comoros Islands with Carpenter syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20358613" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : RAB23 mutation in a large family from Comoros Islands with Carpenter syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162549" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Carpenter syndrome: a review for the craniofacial surgeon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162549" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Carpenter syndrome: a review for the craniofacial surgeon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8988167" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Mutations of the TWIST gene in the Saethre-Chotzen syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9792856" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10094188" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Mutations within or upstream of the basic helix-loop-helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10749989" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11342579" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Oxycephaly (turmschadel), its neuro-psychiatric symptoms, pathogenesis, and heredity</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Unusual familial developmental disturbance of face (acrocephalosyndactylia, craniofacial dysostosis and hypertelorism)</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
